abstract |
The invention belongs to the field of medicinal chemistry and provides a compound whose structural formula is as follows: , ,or , this type of compound has been tested to have the effect of inhibiting the activity of HMG-coA reductase, and can be used as a new generation of potential HMG-coA reductase inhibitors. |